Research Antibodies and Reagents Market to be Worth $6.77 Billion by 2031

Research Reagents Market to be Worth $6.77 Billion by 2031 Antibodies and

Global XXX Market 2016-2022 Meticulous Research a leading global market research company, published a research report titled, Research Antibodies and Reagents Market by Product (Antibodies {Type [Primary, Secondary]} {Production [mAb, pAb]} {Source [Mouse, Rabbit]} Research Area} Media, Stains, Enzyme) Technology (ELISA, Flow Cytometry), Application Global Forecast to 2031. According to this latest publication from Meticulous Research , the global Research antibodies and reagents market is projected to reach $6.77 billion by 2031, at a CAGR of 6.5% during the forecast period 2024 2031. The growth of this market is driven by the rising proteomics and genomics research studies, increase in research funding, and growing industry-academia collaboration. However, the high cost and time for identification and development of potential antibodies hinder the growth of this market. Furthermore, the growing applications of antibodies in clinical trials and medical research, growing research activities in developing countries, and the growing need for new biomarker identification are expected to generate growth opportunities for the players operating in the research antibodies and reagents market. However, issues related to the quality and stability of research antibodies are the major challenges impacting market growth. Key Players The key players operating in the global Research antibodies and reagents market are Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann La-Roche AG (Switzerland), Agilent Technologies, Inc. (U.S.), Becton, Dickinson and Company (U.S.), PerkinElmer, Inc. (U.S.), GenScript Biotech Corporation (U.S.), Bio-Techne Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Santa Cruz Biotechnology, Inc. (U.S.), BioLegend, Inc. (U.S.), Abcam Plc (U.K.), OriGene Technologies, Inc. (U.S.), and Cell Signaling Technology, Inc. (U.S.) Research antibodies and reagents market: Future Outlook The global Research antibodies and reagents market is segmented by Product (Antibodies [Type {Primary Antibodies and Secondary Antibodies}, Clonality {Monoclonal, Polyclonal, Recombinant}, Source {Mouse, Rabbit, Other Sources}, Research Area {Oncology, Infectious Diseases, Cardiology, Immunology, Neurology, Stem Cell, Other Research Areas}], Reagent [Sample Preparation Reagents {Media and Serum, Stains and Dyes, Probes, Buffers, Solvents}, Antibody Production Reagents {Enzymes, Proteins}, Other Research Reagents], Technology (Flow Cytometry, Immunofluorescence, Enzyme-linked Immunosorbent Assay, Multiplex Immunosorbent Assay, Western Blot, Immunohistochemistry, Immunoprecipitation, Other Technologies), Application (Proteomics, Drug Discovery and Development, Genomics), End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations), and geography. The study also evaluates industry competitors and analyzes the market at regional and country levels. Page 1 of 3 Meticulous Research| sales@meticulousresearch.com

Global XXX Market 2016-2022 Based on product, the global research antibodies and reagents market is segmented into antibodies and reagents. In 2024, the antibodies segment is expected to account for the largest share of the global research antibodies and reagents market. The large market share of this segment is attributed to the availability of antibodies for a wide range of applications in medical and biomedical research, the use of antibodies in drug discovery & development, and the high use of antibodies in proteomics research. Based on technology, the global research antibodies and reagents market is segmented into flow cytometry, immunofluorescence, immunoprecipitation, multiplex immunosorbent assay, immunohistochemistry, western blot, and other technologies. In 2024, the flow cytometry segment is expected to account for the largest share of the research antibodies and reagents market. The large market share of this segment is attributed to the increasing research activities in proteomics & cell-based research by universities and pharmaceutical and biotechnological companies and the availability of a wide number of antibody-specific fluorescent tags. enzyme-linked immunosorbent assay, Based on application, the global research antibodies and reagents market is segmented into proteomics, drug discovery & development, and genomics. In 2024, the proteomics segment is expected to account for the largest share of the research antibodies and reagents market. The large market share of this segment is attributed to the upsurge in proteomic research due to the rising need for designing more effective drugs through protein-based disease profiling, rising demand for personalized & protein therapeutics, and increasing public & private sector spending on proteomic research. Based on end user, the global research antibodies and reagents market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations. In 2024, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the research antibodies and reagents market. The large market share of this segment is attributed to the large R&D expenditure, growing demand for protein therapeutics, and high adoption of research antibodies & regents in the proteomics research for drug discovery and development. Geographic Review This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Spain, Italy, Switzerland, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, Singapore, Rest of Asia- Pacific), Latin America (Brazil, Mexico, Rest of Latin America), and Middle East & Africa. Based on geography, in 2024, North America is expected to account for the largest share of the global research antibodies and reagents market, followed by Europe and Asia-Pacific. The large market share of this region is attributed to the well-established healthcare system in the region, higher acceptance of advanced technologies, rising incidence of non-communicable diseases, increasing drug discovery programs & related rise in pharmaceutical research & Page 2 of 3 Meticulous Research| sales@meticulousresearch.com

Global XXX Market 2016-2022 development, rising focus on proteomics and genomics research, higher research funding, and presence of many key players in this market. Download @ https://www.meticulousresearch.com/download-sample- report/cp_id=5055 Sample Report Here Key questions answered in the report: What is the current value of revenue generated by the sale of research antibodies and reagents across the globe? At what rate is the demand for global research antibodies and reagents projected to grow for the next 5-7 years? What is the historical market size and growth rate for research antibodies and reagents across the globe? What are the major factors impacting the growth of this market at the global and regional levels? What are the major opportunities for existing market players and new entrants in the market? Which segments are creating major traction for the vendors in this market in terms of product, technology, application, and end user? What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the global research antibodies and reagents market? Who are the major players in the global research antibodies and reagents market? And what are their specific products offered in the industry? What are the recent developments in the global research antibodies and reagents market, and how these strategic developments are creating a global impact in this market? Contact Meticulous Email- sales@meticulousresearch.com Contact Connect with us on research Us: Research Sales- +1-646-781-8004 LinkedIn- https://www.linkedin.com/company/meticulous- Page 3 of 3 Meticulous Research| sales@meticulousresearch.com